Brief: Vector Science & Therapeutics Names Dexter Fowler As Chief Athletic Officer For Its Valor Platform12/06/2026 12:10
Brief: Vector Science And Therapeutics Enters Option To Buy Up To 15% Of Lyogenesis Plus For Up To $1 Million13/05/2026 18:05
Brief: Vector Science & Therapeutics Enters Three-Year Development And Manufacturing Agreement With MPP Group LLC11/05/2026 14:18
Last trade - 00:00Last trade - 00:00Last trade - 00:00